HORIBA Businesses Invest in R&D Site, Acquire MedTest Holdings

HORIBA FRANCE SAS, a developer of Raman spectroscopy systems and technology, inaugurated a new site in Loos, France. The facility replaces the company’s former location in Villeneuve d’Ascq. In a press release, HORIBA said the production and R&D site will enable the company to meet the increasing demand for Raman spectroscopy.

The new building will increase manufacturing capacity by 30%, HORIBA said, and will be a technological showcase for all of HORIBA’s present and future customers. The site, with a surface area of 6764 sq m on a 14,500-sq-m parcel, includes R&D and applications laboratories, large production areas (mechanical, optical, electronic), and sales and customer support areas.

HORIBA said its new R&D and production facility will increase manufacturing capacity by 30%. Courtesy of HORIBA FRANCE SAS.

In a separate move, HORIBA Ltd. and HORIBA Instruments acquired MedTest Holdings Inc., a provider of clinical testing solutions with open channel reagents for chemistry, drugs of abuse, and toxicology testing solutions. MedTest Holdings is composed of MedTest Dx Inc., Pointe Scientific Inc., Clintox Diagnostics Inc., and Medical Laboratory Solutions Inc. HORIBA said that the acquisition will combine the complementary innovative technology offerings of the HORIBA Medical segment (HORIBA Medical) with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, and expand HORIBA’s laboratory chemistry offerings.